MARSHA MCCARY: Open Payments
NPI 1396389532 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 60 payments from 12 companies in 2025. Trend: 2023 $1 · 2024 $412 · 2025 $1,712
Food & beverage: $1,712
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $484 |
| Alexion Pharmaceuticals, Inc. | 2 | $244 |
| Ipsen Biopharmaceuticals, Inc | 10 | $212 |
| Gilead Sciences, Inc. | 7 | $188 |
| Aimmune Therapeutics, Inc. | 11 | $178 |
| ABBVIE INC. | 6 | $145 |
| Intercept Pharmaceuticals, Inc. | 6 | $110 |
| ORPHALAN INC | 3 | $52 |
| Novo Nordisk Inc | 2 | $38 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
Products named: REZDIFFRA, IQIRVO, ZENPEP, MAVYRET, Livdelzi, OCALIVA, CUVRIOR, Wegovy.
Industry payments across AZ — which companies pay providers there.
